Novolax (Bisacodyl)

Bisacodyl, the active ingredient in Novolax, is a stimulant laxative presented as a tablet for oral use. It is used to stimulate bowel movements in adults and children experiencing occasional constipation. GNH USA supplies Novolax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novolax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bisacodyl acts on the lower gastrointestinal tract to facilitate evacuation in several constipation‑related conditions.

- Constipation: promotes bowel movements and relieves occasional constipation. - Bowel preparation for diagnostic procedures: assists in clearing the colon before endoscopy or radiology exams. - Opioid‑induced constipation: helps counteract reduced motility caused by opioid therapy. - Post‑operative ileus: supports the return of normal bowel function after surgery.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps - Diarrhea - Nausea - Flatulence - Urgency to defecate - Mild electrolyte imbalance

Serious or Rare Side Effects: - Severe dehydration - Electrolyte disturbances (e.g., hypokalemia) - Rectal bleeding - Persistent abdominal pain - Allergic reactions such as rash or angioedema

When using Bisacodyl, consider the following safety measures:

- Dosage adjustment: tailor the dose for pediatric patients and the elderly. - Hydration: maintain adequate fluid intake to reduce risk of dehydration. - Electrolyte monitoring: watch for signs of electrolyte imbalance during prolonged use. - Contraindications: avoid in patients with intestinal obstruction, acute abdominal conditions, or known hypersensitivity. - Drug interactions: review concomitant medications for potential additive effects on gut motility. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Bisacodyl can interact with other agents that affect gastrointestinal motility or electrolyte balance.

Major Interactions (Avoid): - Anticholinergic drugs: may reduce the laxative effect of Bisacodyl. - Loop diuretics: increase risk of electrolyte disturbances, especially hypokalemia.

Moderate Interactions (Monitor Closely): - Opioid analgesics: may counteract the pro‑kinetic action of Bisacodyl. - Mineral‑type Mineral Miner ​   t   t   t  t  t

-   t  t -   o   t -   t  t -  t -  -  t -  -  -  -  -  -  t -  -  t